Filing Flows › Kura Oncology (KURA) › Q1 2026 › vs Q4 2025
Kura Oncology (KURA) Q1 2026 vs Q4 2025 (quarter over quarter)
Kura Oncology's revenue rose $929K (+5%) from $17.3M in Q4 2025 to $18.3M in Q1 2026.
Kura Oncology, Q1 2026: revenue $18.3M (+30% year over year), operating margin -431.5%, net loss $73.3M, operating cash flow −$85.9M. The chart draws each line against Q4 2025, the increases inside each band.
Every line
| Line | Q1 2026 | Q4 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $18.3M | $17.3M | $929K | +5% |
| Other income, net | $5.5M | $5.3M | $150K | +3% |
| Net loss | $73.3M | $81.0M | −$7.7M | -9% |
| Costs & expenses | $97.1M | $104M | −$6.6M | -6% |
| Operating costs | $97.1M | $104M | −$6.5M | -6% |
| Income tax | $8K | $71K | −$63K | -89% |
| Research & development | $65.3M | $64.4M | $855K | +1% |
| Operating cash sources | $94.6M | −$106M | $200M | — |
| Depreciation | $355K | $403K | −$48K | -12% |
| Share-based compensation | $8.4M | $11.4M | −$2.9M | -26% |
| Cash used in operations | $85.9M | −$117M | $203M | — |
| Net loss absorbed | $73.3M | $81.0M | −$7.7M | -9% |
| Working capital & other | $21.3M | −$187M | $208M | — |
Questions
How much did Kura Oncology's revenue grow quarter over quarter in Q1 2026?
Kura Oncology's revenue rose $929K (+5%) from $17.3M in Q4 2025 to $18.3M in Q1 2026.